DE69625678D1 - Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2 - Google Patents
Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2Info
- Publication number
- DE69625678D1 DE69625678D1 DE69625678T DE69625678T DE69625678D1 DE 69625678 D1 DE69625678 D1 DE 69625678D1 DE 69625678 T DE69625678 T DE 69625678T DE 69625678 T DE69625678 T DE 69625678T DE 69625678 D1 DE69625678 D1 DE 69625678D1
- Authority
- DE
- Germany
- Prior art keywords
- breast cancer
- relates
- brca2
- human
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US576559 | 1984-02-03 | ||
US57377995A | 1995-12-18 | 1995-12-18 | |
US573779 | 1995-12-18 | ||
US57535995A | 1995-12-20 | 1995-12-20 | |
US575359 | 1995-12-20 | ||
US57655995A | 1995-12-21 | 1995-12-21 | |
US58539196A | 1996-01-11 | 1996-01-11 | |
US585391 | 1996-01-11 | ||
US639501 | 1996-04-29 | ||
US08/639,501 US5837492A (en) | 1995-12-18 | 1996-04-29 | Chromosome 13-linked breast cancer susceptibility gene |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69625678D1 true DE69625678D1 (de) | 2003-02-13 |
DE69625678T2 DE69625678T2 (de) | 2003-11-06 |
DE69625678T3 DE69625678T3 (de) | 2006-11-09 |
Family
ID=27541925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69625678T Expired - Lifetime DE69625678T3 (de) | 1995-12-18 | 1996-12-17 | Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2 |
Country Status (11)
Country | Link |
---|---|
US (2) | US6124104A (de) |
EP (1) | EP0785216B2 (de) |
JP (1) | JP3455228B2 (de) |
AT (1) | ATE230759T1 (de) |
AU (1) | AU1461597A (de) |
CA (1) | CA2239733C (de) |
DE (1) | DE69625678T3 (de) |
IL (1) | IL124620A0 (de) |
NO (1) | NO982785L (de) |
NZ (1) | NZ326525A (de) |
WO (1) | WO1997022689A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030022184A1 (en) * | 1996-02-12 | 2003-01-30 | Oncormed. Inc. | Coding sequences of the human BRCA1 gene |
US6838256B2 (en) | 1996-02-12 | 2005-01-04 | Gene Logic Inc. | Coding sequences of the human BRCA1 gene |
CA2273051A1 (en) * | 1996-12-03 | 1998-06-11 | Prasanna Athma | Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus |
GB9708221D0 (en) * | 1997-04-23 | 1997-06-11 | Cancer Res Campaign Tech | Substances and uses thereof |
US20090269814A1 (en) * | 1998-05-22 | 2009-10-29 | Murphy Patricia D | Method of Analyzing a BRCA2 Gene in a Human Subject |
EP2275575A3 (de) * | 1997-08-15 | 2012-07-11 | Gene Logic Inc. | Menschliche BRCA2-Gen-kodierende Sequenzhaplotypen |
US6492109B1 (en) | 1997-09-23 | 2002-12-10 | Gene Logic, Inc. | Susceptibility mutation 6495delGC of BRCA2 |
US6051379A (en) * | 1997-09-23 | 2000-04-18 | Oncormed, Inc. | Cancer susceptibility mutations of BRCA2 |
US6686163B2 (en) | 1998-05-06 | 2004-02-03 | Gene Logic Inc. | Coding sequence haplotype of the human BRCA1 gene |
US20030180789A1 (en) * | 1998-12-30 | 2003-09-25 | Dale Roderic M.K. | Arrays with modified oligonucleotide and polynucleotide compositions |
US6087112A (en) * | 1998-12-30 | 2000-07-11 | Oligos Etc. Inc. | Arrays with modified oligonucleotide and polynucleotide compositions |
US7148016B1 (en) * | 1999-01-14 | 2006-12-12 | Ca*Tx Inc. | Immunoassays to detect diseases or disease susceptibility traits |
AUPQ421699A0 (en) * | 1999-11-24 | 1999-12-16 | University Of Western Australia, The | Tumour suppressor factor |
US20050013803A1 (en) * | 2000-07-07 | 2005-01-20 | Benjamin Thomas L. | Diagnosing and treating cancer cells using mutant viruses |
US20030157481A1 (en) * | 2001-12-10 | 2003-08-21 | Benjamin Thomas L. | Diagnosing and treating cancer cells using T-HR mutants and their targets |
US20030093819A1 (en) | 2000-11-03 | 2003-05-15 | D'andrea Alan D. | Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof |
US20030188326A1 (en) * | 2000-11-03 | 2003-10-02 | Dana Farber Cancer Institute | Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof |
US6816789B2 (en) * | 2001-04-19 | 2004-11-09 | Varian, Inc. | Method and system for analyzing chromatograms |
AU2002323841B2 (en) * | 2001-06-05 | 2008-05-22 | Auckland Uniservices Limited | Methods and compositions for assessment of pulmonary function and disorders |
AU2002359398A1 (en) * | 2001-11-16 | 2003-06-10 | Exelixis, Inc. | Nucleic acids and polypeptides of invertebrate brca2 and methods of use |
CA2468197A1 (en) * | 2001-11-29 | 2003-06-05 | Therakos, Inc. | Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
CA2608142A1 (en) * | 2005-05-10 | 2006-11-16 | Synergenz Bioscience Limited | Methods and compositions for assessment of pulmonary function and disorders |
CA2608161A1 (en) * | 2005-05-19 | 2006-11-23 | Synergenz Bioscience Limited | Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms |
AU2006248200A1 (en) * | 2005-05-19 | 2006-11-23 | Synergenz Bioscience Limited | Methods and compositions for assessment of pulmonary function and disorders |
US7933722B2 (en) * | 2005-05-20 | 2011-04-26 | Synergenz Bioscience Limited | Methods of analysis of polymorphisms and uses thereof |
IL282783B2 (en) | 2006-05-18 | 2023-09-01 | Caris Mpi Inc | A system and method for determining a personalized medical intervention for a disease stage |
US8768629B2 (en) | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
PL2134876T3 (pl) * | 2006-06-22 | 2014-10-31 | Pomorski Univ Medyczny | Określanie predyspozycji do raka piersi poprzez identyfikację kombinacji genotypu specyficznych wariantów genów CYP1B1, BRCA2 oraz CHEK2 |
WO2008021288A2 (en) * | 2006-08-11 | 2008-02-21 | Johns Hopkins University | Consensus coding sequences of human breast and colorectal cancers |
US7993835B1 (en) * | 2007-05-11 | 2011-08-09 | Myriad Genetics, Inc. | BRCA2 mutations and use thereof |
EP3075864A1 (de) * | 2008-10-14 | 2016-10-05 | Caris MPI, Inc. | Gen und genexprimierte zielproteine zur darstellung von biomarkermustern und signatursets nach tumortyp |
CN107254538A (zh) * | 2008-11-12 | 2017-10-17 | 卡里斯生命科学瑞士控股有限责任公司 | 使用外来体来确定表现型的方法和系统 |
US20130029926A1 (en) * | 2009-11-05 | 2013-01-31 | Myriad Genetics, Inc. | Compositions and methods for determing cancer susceptibility |
JP5808349B2 (ja) | 2010-03-01 | 2015-11-10 | カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー | セラノーシスのためのバイオマーカー |
CA2795776A1 (en) | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers for disease |
US20130018700A1 (en) * | 2011-07-14 | 2013-01-17 | International Business Machines Corporation | Optimizing product portfolios under customer choice |
US20140222512A1 (en) * | 2013-02-01 | 2014-08-07 | Goodsnitch, Inc. | Receiving, tracking and analyzing business intelligence data |
US20140343982A1 (en) * | 2013-05-14 | 2014-11-20 | Landmark Graphics Corporation | Methods and systems related to workflow mentoring |
CN106852176A (zh) * | 2014-03-25 | 2017-06-13 | 凡弗3基因组有限公司 | 用于功能证实癌症突变的rna分析的系统和方法 |
US10133996B2 (en) * | 2014-04-22 | 2018-11-20 | International Business Machines Corporation | Object lifecycle analysis tool |
CN104962613B (zh) * | 2015-06-02 | 2019-12-03 | 南京医科大学 | 一种用于乳腺癌辅助诊断的突变基因及其应用 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
CA1188246A (en) | 1981-08-31 | 1985-06-04 | Jerry L. Gregory | Immobilized microbe recycle apparatus |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4868105A (en) | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
US5773278A (en) † | 1991-05-03 | 1998-06-30 | Mount Sinai Medical Center | Acid sphingomyelinase gene |
IL103059A0 (en) | 1991-09-30 | 1993-02-21 | Boehringer Ingelheim Int | Conjugates for introducing nucleic acid into higher eucaryotic cells |
US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
AU1214995A (en) * | 1993-11-30 | 1995-06-19 | California Pacific Medical Center Research Institute | Cdna probe for breast cancer diagnosis and treatment |
WO1995019369A1 (en) * | 1994-01-14 | 1995-07-20 | Vanderbilt University | Method for detection and treatment of breast cancer |
ATE259378T1 (de) * | 1995-11-23 | 2004-02-15 | Cancer Res Campaign Tech | Materialien und methoden mit bezug zur identifizierung und sequenzierung des krebs- suszeptilitaetsgens brca2 und dessen anwendungen |
GB2307477B (en) * | 1995-11-23 | 1997-10-22 | Cancer Res Campaign Tech | Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
US5879890A (en) † | 1997-01-31 | 1999-03-09 | The Johns Hopkins University | APC mutation associated with familial colorectal cancer in Ashkenazi jews |
CA2289109A1 (en) † | 1997-04-30 | 1998-11-05 | Genzyme Limited | Carbohydrate-deficient glycoprotein syndrome type i |
WO1998055650A1 (en) † | 1997-06-04 | 1998-12-10 | Rijksuniversiteit Te Leiden | A diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination |
US6376176B1 (en) † | 1999-09-13 | 2002-04-23 | Cedars-Sinai Medical Center | Methods of using a major histocompatibility complex class III haplotype to diagnose Crohn's disease |
BR0109192A (pt) † | 2000-03-16 | 2003-05-27 | Sucampo Ag | Tratamento de hipertensão ocular e glaucoma. |
EP1280814A4 (de) † | 2000-04-13 | 2003-05-14 | Genaissance Pharmaceuticals | Assoziation der haplotypen des beta2 adrenergenen rezeptors mit der medikamentenwirksamkeit |
EP1430081A2 (de) † | 2001-06-13 | 2004-06-23 | Centre National De La Recherche Scientifique (Cnrs) | Molekuläre komplexe brca1/acc alpha, diagnostische und therapeutische verwendungen |
-
1996
- 1996-12-17 DE DE69625678T patent/DE69625678T3/de not_active Expired - Lifetime
- 1996-12-17 AU AU14615/97A patent/AU1461597A/en not_active Abandoned
- 1996-12-17 JP JP52287197A patent/JP3455228B2/ja not_active Expired - Lifetime
- 1996-12-17 CA CA002239733A patent/CA2239733C/en not_active Expired - Fee Related
- 1996-12-17 AT AT96309211T patent/ATE230759T1/de active
- 1996-12-17 WO PCT/US1996/019598 patent/WO1997022689A1/en active Application Filing
- 1996-12-17 EP EP96309211A patent/EP0785216B2/de not_active Expired - Lifetime
- 1996-12-17 IL IL12462096A patent/IL124620A0/xx unknown
- 1996-12-17 NZ NZ326525A patent/NZ326525A/xx not_active IP Right Cessation
-
1998
- 1998-03-20 US US09/044,908 patent/US6124104A/en not_active Expired - Lifetime
- 1998-03-20 US US09/044,946 patent/US6033857A/en not_active Expired - Lifetime
- 1998-06-17 NO NO982785A patent/NO982785L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO982785D0 (no) | 1998-06-17 |
ATE230759T1 (de) | 2003-01-15 |
CA2239733A1 (en) | 1997-06-26 |
IL124620A0 (en) | 1998-12-06 |
EP0785216B2 (de) | 2006-06-07 |
EP0785216B1 (de) | 2003-01-08 |
DE69625678T3 (de) | 2006-11-09 |
CA2239733C (en) | 2001-04-03 |
NO982785L (no) | 1998-08-17 |
WO1997022689A1 (en) | 1997-06-26 |
NZ326525A (en) | 1999-11-29 |
US6033857A (en) | 2000-03-07 |
AU1461597A (en) | 1997-07-14 |
EP0785216A1 (de) | 1997-07-23 |
JP3455228B2 (ja) | 2003-10-14 |
DE69625678T2 (de) | 2003-11-06 |
US6124104A (en) | 2000-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69625678T2 (de) | Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2 | |
EP1260520A3 (de) | Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2 | |
MX9701075A (es) | Mutaciones en vivo y polimorfismos en el gen de susceptibilidad al cancer de pecho y ovario enlazado con 17q. | |
CA2196795A1 (en) | Method for diagnosing a predisposition for breast and ovarian cancer | |
MX9701074A (es) | Gen de susceptibilidad al cancer de pecho y ovario enlazado con 17q. | |
WO2001085911A3 (en) | Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: THE UNIVERSITY OF UTAH RESEARCH FOUNDATION, SALT L Owner name: ENDO RECHERCHE INC., QUEBEC, CA Owner name: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, PH Owner name: HSC RESEARCH AND DEVELOPMENT LTD. PARTNERSHIP, TOR |